Nature's Miracle Holding Inc. NMHI
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 0.0×
Follow NMHI
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 27.40 | 0.26 | 0.94 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | (283.79) | (0.89) | (0.75) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 28.08 | 0.86 | 5.98 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | (149.28) | (1.35) | (2.61) |
EV/FCF |
0.00 | (149.28) | (1.35) | (2.60) |
Quick Ratio |
0.26 | 0.12 | 0.16 | 0.01 |
Current Ratio |
0.80 | 0.50 | 0.26 | 0.04 |
Net Debt/EBITDA |
(1.75) | (1.37) | (0.57) | (1.57) |
Debt/Assets |
14.76% | 44.00% | 52.86% | 43.45% |
Debt/Equity |
4.99 | (0.93) | (0.42) | (0.70) |
Asset Turnover |
0.00 | 0.51 | 0.73 | 0.11 |
Operating CF/Net income |
1.00 | 0.23 | 0.43 | 0.33 |
Capex/Depreciation |
(0.11) | 0.00 | 0.00 | 0.02 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 240.50% | 129.67% | 88.53% | |
| 0.00% | (41.87%) | (107.03%) | (75.57%) | |
ROIC |
(38.41%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(187.24%) | 247.35% | 131.86% | 305.04% |
Average Days of Receivables |
69.69 | 63.00 | 110.56 | 32.05 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
18.49% | 35.36% | 77.03% | 280.25% |
Intangible Assets out of Total Assets |
0.05 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 15.26% | 19.60% |
Graham Net Nets |
0.00 | (0.06) | (8.37) | (19.61) |
Graham Number |
0.00 | 44.87 | 57.95 | 3.88 |
Earnings Yield |
(3.00%) | (3.00%) | (561.69%) | (712.91%) |
Free Cash Flow Yield |
0.00% | (0.69%) | (242.43%) | (244.33%) |
Revenue per Share |
33.47 | 12.03 | 8.06 | 0.12 |
Operating CF per Share |
(4.41) | (2.26) | (5.16) | (0.27) |
Capex per Share |
(0.10) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(4.50) | (2.26) | (5.16) | (0.27) |
Cash per Share |
1.46 | 0.30 | 0.37 | 0.01 |
Shareholders Equity per Share |
1.11 | (9.05) | (12.48) | (0.85) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.11 | (9.05) | (12.48) | (0.85) |
Free Cash Flow |
(2.51) | (1.68) | (5.93) | (3.96) |
Working Capital |
(3.27) | (7.37) | (14.60) | (22.30) |
Capital Expenditures |
(0.05) | — | — | 0.03 |
Net Current Asset Value |
(6.78) | (13.51) | (20.49) | (32.20) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | (0.01) |
Net Profit Margin |
(13.22%) | (82.15%) | (147.42%) | (687.93%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.10 | 0.37 | 0.15 | 0.09 |
Cash ROIC |
(156.27%) | 2,440.42% | 128.24% | 592.26% |
Accounts Receivable Turnover |
0.00 | 3.51 | 4.26 | 1.18 |
Accounts Payable Turnover |
0.00 | 0.87 | 1.12 | 0.21 |
Inventory Turnover |
0.00 | 1.43 | 3.54 | 0.00 |
Average Days of Payables |
257.09 | 398.63 | 323.61 | 1,672.62 |
Days of Inventory on Hand |
189.52 | 186.39 | 53.80 | 0.00 |
Average Receivables |
— | 2.55 | 2.17 | 1.48 |
Average Payables |
— | 11.37 | 10.75 | 10.37 |
Average Inventory |
— | 6.92 | 3.41 | — |
Average Assets |
— | 17.52 | 12.76 | 15.86 |
Average Common Equity |
— | (3.05) | (10.53) | (13.54) |
Columns are period end dates